Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Effects of Dalfampridine on Cognition in Multiple Sclerosis [Phase 2, Phase 3]
Clinical trial update on dalfampridine assessing cognitive effects in multiple sclerosis across Phase 2 and Phase 3, with completed status a…
-
CLINICAL_TRIALS trial_result · 2019-03-13Clinical Trial Update: The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) [Phase 3]
Phase 3 trial evaluating laquinimod for relapsing-remitting multiple sclerosis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-06Clinical Trial Update: Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients [Phase 4]
A Phase 4 clinical trial evaluated prolonged-release fampridine as an adjunct to active motor training in patients with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: How Does Strength Training and Balance Training Affect Gait Function and Fatigue in Patients With Multiple Sclerosis? [NA]
A completed clinical trial evaluating whether strength training and balance training improve gait function and fatigue in people with multip…
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Upper Extremity Function, Shoulder Position Sense and Disability Level İn Patients With Multiple Sclerosis [NA]
A completed clinical trial from Ankara Yildirim Beyazıt University studied upper extremity function, shoulder position sense, and disability…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis
A completed clinical trial evaluating fampridine's impact on cognition, fatigue, depression, and quality of life in individuals with multipl…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Study to Evaluate the Reliability and Validity of the Modified Manual Muscle Test for Persons With MS [NA]
A completed study evaluating the reliability and validity of the Modified Manual Muscle Test in persons with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: LEAP a New Overground Body Weight Support Robot: Usability Trial [NA]
Completed usability trial of the LEAP overground body weight support robot evaluating its usability across conditions including spinal cord …
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Cognitive Functions in Patients With Multiple Sclerosis
This clinical trial study completed its evaluation of cognitive functions in people with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: The Effect of Task-Oriented Training in Patients With Multiple Sclerosis [NA]
A completed clinical trial assessing the effectiveness of task-oriented training in patients with multiple sclerosis, sponsored by Gazi Univ…
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Vestibular Rehabilitation for Persons With Multiple Sclerosis: Who Benefits the Most? (MSVR3trial) [NA]
A completed clinical trial (MSVR3) evaluating vestibular rehabilitation in people with multiple sclerosis to determine which patients benefi…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Central Pain Study for ABX-1431 [Phase 1]
Phase 1 central pain study of ABX-1431 conducted by Abide Therapeutics has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Assessing Fatiguability of Tongue Muscles in MS [NA]
A clinical trial sponsored by Thomas More Kempen is assessing fatigability of tongue muscles in people with Multiple Sclerosis to explore sw…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Feasibility and Reliability of Multimodal Evoked Potentials
This completed clinical trial assesses the feasibility and reliability of multimodal evoked potentials in individuals with multiple sclerosi…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1a [Phase 2]
Phase 2 trial evaluating a curcumin dietary supplement in patients with active relapsing multiple sclerosis treated with subcutaneous interf…
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: MEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS)
A clinical trial evaluating satisfaction with Rebif after initial treatment for multiple sclerosis was terminated. Results were posted on 20…
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Interferon ß-1b Treatment by Cyclical Administration [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating cyclical interferon β-1b treatment for multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple Sclerosis [Phase 2]
Phase 2 trial update for masitinib in primary progressive or relapse-free secondary progressive multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: Alemtuzumab on Surrogate Markers of Disease Activity and Repair Using Advanced MRI Measures in Subjects With Relapsing Remitting Multiple Sclerosis [Phase 4]
Phase 4 clinical trial evaluating alemtuzumab on MRI surrogate markers of disease activity and repair in relapsing remitting multiple sclero…
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) [Phase 3]
Phase 3 trial update of BG00012 (Dimethyl Fumarate) in Asian subjects with relapsing-remitting multiple sclerosis (RRMS) has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: Aspirin as a Pre-Treatment for Exercise in Multiple Sclerosis [EARLY_Phase 1]
Early phase 1 trial investigating aspirin as a pre-treatment to exercise in individuals with fatigue-related symptoms in multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2018-11-19Clinical Trial Update: Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding Study [Phase 1]
Phase 1 safety and dose-finding study of thyroid hormone for remyelination in multiple sclerosis completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis [Phase 1]
Phase 1 safety and tolerability study of MEDI-551, a B-cell depleting agent, for relapsing forms of multiple sclerosis completed with result…
-
CLINICAL_TRIALS trial_result · 2018-10-18Clinical Trial Update: Evaluate Safety and Efficacy of Apitox Add-on Therapy for Improving Disability and Quality of Life in MS Patients [Phase 3]
Phase 3 clinical trial evaluating safety and efficacy of Apitox as an add-on therapy to improve disability and quality of life in multiple s…
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Effect of Photobiomodulation Treatment in Individuals With Multiple Sclerosis: [Phase 2]
A Phase 2 clinical trial evaluating photobiomodulation treatment in individuals with Multiple Sclerosis; current status is unknown.